INS and type 2 diabetes mellitus: Even though this cohort of T2D subjects is very small, it is also true that is composed of a very controlled group of patients not insulin-dependent taking the same class of drugs, with no other major comorbidities and below 65 years of age (mean age ± SD: 59 ± 5).